Clinical Trial Update: Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating TJ033721 (Givastomig) in adults with advanced or metastatic solid tumors; the study is currently recruiting and includes gastric cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Esophageal Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Givastomig (TJ033721)

Snippet

Sponsor: I-Mab Biopharma US Limited | Conditions: Solid Tumor, Advanced Cancer | Phase 1 | Status: RECRUITING